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A major unanswered question in neuroscience is
whether there exists genomic variability between
individual neurons of the brain, contributing to func-
tional diversity or to an unexplained burden of
neurological disease. To address this question, we
developed a method to amplify genomes of single
neurons from human brains. Because recent reports
suggest frequent LINE-1 (L1) retrotransposition in
human brains, we performed genome-wide L1 inser-
tion profiling of 300 single neurons from cerebral
cortex and caudate nucleus of three normal individ-
uals, recovering >80% of germline insertions from
single neurons. While we find somatic L1 insertions,
we estimate <0.6 unique somatic insertions per
neuron, and most neurons lack detectable somatic
insertions, suggesting that L1 is not a major gener-
ator of neuronal diversity in cortex and caudate. We
then genotyped single cortical cells to characterize
the mosaicism of a somatic AKT3mutation identified
in a child with hemimegalencephaly. Single-neuron
sequencing allows systematic assessment of geno-
mic diversity in the human brain.
INTRODUCTION
It is unlikely that the genomes of any two cells in the body are
identical, due to somatic mutations during replication and othermutagenic forces (Frumkin et al., 2005). The complexity and
diversity of neuronal cell types in the brain have also led to
suggestions that a somatic mutational mechanism may have
been harnessed evolutionarily to diversify neuronal function
(Muotri and Gage, 2006; Rehen et al., 2005). Endogenous re-
trotransposition of LINE-1 elements has been proposed as one
potential mechanism generating neuronal genome diversity
(Singer et al., 2010). Human-specific LINE-1 (L1Hs) retrotranspo-
sons comprise the only known active autonomous transposon
family in humans, with 80–100 active L1Hs elements per
individual (Hancks and Kazazian, 2012), and somatic L1Hs
insertions have been found both in cancerous and normal cells
(Iskow et al., 2010; Lee et al., 2012a; Miki et al., 1992; Van den
Hurk et al., 2007). Recent studies observed rare retrotransposi-
tion of an L1Hs reporter in rodent brain in vivo (Muotri et al.,
2005, 2010) and human neural progenitors in vitro (Coufal
et al., 2009), whereas other studies found evidence for more
widespread somatic L1Hs insertions in the human brain by
qPCR (Coufal et al., 2009) and bulk DNA sequencing (Baillie
et al., 2011). qPCR estimates of these events in human brain
approach 80 somatic insertions per cell (Coufal et al., 2009).
Although L1 retrotransposition and other somatic mutations
could contribute to functional genomic diversity, they can also
cause disease (Erickson, 2010; Hancks and Kazazian, 2012).
Therefore, any potential somatic mutational mechanism must
be balanced by the need for genome stability. Somatic muta-
tions cause not only cancers, but also several malformations of
the brain (Gleeson et al., 2000; Rivie`re et al., 2012), emphasized
by the recent identification of somatic mutations affecting genes
of the PI3K-AKT3-mTOR pathway in hemimegalencephaly
(HMG) (Lee et al., 2012b; Poduri et al., 2012), a severe epilepticCell 151, 483–496, October 26, 2012 ª2012 Elsevier Inc. 483
brain malformation. However, the rates and types of somatic
mutations occurring during normal brain development and
how much of the unexplained burden of neurogenetic disease
may be caused by somatic mutations are unknown (Erickson,
2010).
Systematically studying somatic mutations requires sequenc-
ing genomes of single cells (Kalisky et al., 2011) because the
signals of somatic mutations present in a minority of cells can
be missed due to sequencing error or insufficient sequencing
depth. Single-cell sequencing overcomes this limitation, as
shown by studies of single human cancer cells and single sperm
that have yielded important new insights into tumor evolution
and genetic heterogeneity (Hou et al., 2012; Navin et al., 2011;
Wang et al., 2012; Xu et al., 2012). However, similar technolo-
gies have yet to be applied to the study of somatic mutation in
normal human tissues such as brain or to diseases other than
cancer.
Here, we describe a method to amplify genomes of single
neurons from postmortem and surgically resected human brain,
enabling interrogation of a wide range of somatic mutations by
high-throughput sequencing. We performed genome-wide
L1Hs insertion profiling of 300 single neurons from cerebral
cortex and caudate nucleus of three neurologically normal
individuals and confirmed that somatic L1Hs retrotransposon
insertions are present in the normal human brain. Our quantita-
tive analysis of >200,000 L1Hs insertion sites in these 300 single
neurons suggests a frequency not higher than 0.6 unique
somatic insertions per neuron and possibly as low as 0.04
(1 insertion in 25 neurons), consistent with observed in vitro rates
for human neural progenitors but substantially less than previous
qPCR-based estimates for human brain (Coufal et al., 2009). We
then sequenced single cells from HMG brain tissue harboring
a known somatic AKT3 point mutation (c.49G/A; p.E17K)
(Poduri et al., 2012), showing that our method can characterize
the mosaicism of pathogenic somatic brain mutations. These
single-cell studies provide a foundation for studying genomic
variability among cells in the human brain, both in normal devel-
opment and in neurologic disease.
RESULTS
High-Throughput Isolation and Amplification
of Single Neuronal Genomes from Human Brains
We purified nuclei from postmortem human frontal cortex and
caudate nucleus and labeled them with a neuron-specific anti-
body (NeuN) for sorting using fluorescence-activated cell sorting
(FACS) (Figure 1A) (Matevossian and Akbarian, 2008; Spalding
et al., 2005). Large nuclei with neuronal nuclear morphology
(Parent and Carpenter, 1996) were readily apparent by micros-
copy (Figure S1A). NeuN immunoreactivity (Figure S1B) (Mullen
et al., 1992) labels essentially all neuronal nuclei in cortex and
caudate (Wolf et al., 1996), corresponding to 25%–35% of all
nuclei (population I; Figures 1B and S1C). Consistent with their
increased size on microscopy (Figure S1B), NeuN+ nuclei also
had larger forward (FSC) and side (SSC) scatter (correlates of
size) by flow cytometry compared to NeuN nuclei (Figure S1D).
Whereas for nuclei isolated from the caudate we performed
a simple sort of the NeuN+ population (population I; Figure S1C),484 Cell 151, 483–496, October 26, 2012 ª2012 Elsevier Inc.we further enriched nuclei from the cortex for pyramidal neuronal
nuclei. Because neighboring cortical pyramidal neurons tend to
have shared clonal origins due to their primarily radial migration
(Magavi et al., 2012), enriching for pyramidal neuronal nuclei
increases the chance of identifying clonal somatic mutations
shared by multiple neurons. The largest neuronal nuclei in cortex
correspond primarily to pyramidal projection neurons (Gittins
and Harrison, 2004; Mills, 2007), and indeed, their nuclei often
show a pyramidal shape (Figure S1A). We therefore sorted
cortical nuclei within the top 25% NeuN/FL-2 fluorescence of
population I (population Ia; Figure 1B), which were the largest
nuclei in population I (Figure S1D). We confirmed the neuronal
and nonneuronal identities of the sorted populations by reverse
transcriptase PCR (RT-PCR) and western blot analysis of addi-
tional neuronal (SNAP25 and SYT1) and nonneuronal (GFAP,
AQP4, and Olig2) markers (Figures 1C and 1D). For every sort,
a portion of the sorted nuclei was reanalyzed by FACS, confirm-
ing that nuclei remained intact during sorting and that sort purity
was >98% (Figures 1B and S1C).
We used multiple displacement amplification (MDA) (Dean
et al., 2002) for whole-genome amplification of single nuclei
because it produces large yields of high molecular weight ampli-
cons, most of which are >30 kb (Hou et al., 2012 and data not
shown), allowing study of both single-nucleotide mutations and
6 kb full-length L1Hs insertions. We optimized MDA reactions
for increased yield (Figure S1E), producing 15–20 mg of amplified
DNA from single cells. We also measured exogenous (non-
human) DNA contamination in the reagents of the MDA reaction
(Blainey and Quake, 2011), finding negligible (<1 fg) exogenous
DNA (Figures S1F and S1G). Additional controls (see following
section) excluded operator human DNA contamination. Quanti-
tative MDA (qMDA) reactions (Zhang et al., 2006) further showed
that, as the number of nuclei sorted in a well increased, the time-
to-threshold-amplification decreased in a stepwise manner
(p < 0.01 for each additional nucleus) (Figure 1E), confirming
that the desired number of nuclei was correctly sorted in each
well. We concluded that our procedure can sort and amplify
single neuronal genomes from human brains with high purity
and in a high-throughput manner.
Genome-wide Coverage and Amplification Dropout
Rates of Single Neuronal Genomes
We next evaluated the genome-wide coverage and reproduc-
ibility of our single neuronal genome amplification. In an initial
four-locus multiplex PCR quality control, 97% of sorted single
neurons amplified at least three of the four loci, indicating that
their genomes were successfully amplified and suitable for
further experiments. We then performed low-coverage whole-
genome sequencing (Figure 2A) of eight randomly chosen single
neurons (0.353 average coverage)—six from a normal individual
(46XY) and two from a trisomy 18 individual—as well as unam-
plified and MDA-amplified bulk reference samples. The two
neurons from the trisomy 18 individual showed the expected
increase in chromosome 18 copy number, and the six single
neurons from the normal individual were all euploid, confirming
that intact nuclei were sorted and that all chromosomes were
amplified (Figure 2B). Counting sequencing reads across the
genome in bins 500 kb in size (Navin et al., 2011) revealed
10
1
10
2
10
3
10
4
10
5
10
1
10
2
10
3
10
4
10
5 0% 100%
0%0%
Sort Post-sort purity
a
α-NeuNUnlabeled
NeuN NeuN NeuN
FL
-2
 b
ac
kg
ro
un
d
Population: la    II la    II la    II la    II la    II
GFAP AQP4SNAP25 SYT1 RPL37A
0 1 2 3 4 5 6 10
0.4
0.6
0.8
1
4
5
6
R2=0.96
Ti
m
e T
(h
ou
rs
)
10-3 10-5 10-4 10-2 10-3 10-3 10-5p <
Number of neuronal nuclei sorted
Population:
NeuN Olig2 HistoneH3
la        II la       II la         II
Purify nuclei
NeuN
labeling
Multiple
Displacement
Amplification
FACS
10×103 or 50×103
unsorted nuclei
1 100 1,000 neuronal nuclei
10
1
10
2
10
3
10
4
10
5
10
1
10
2
10
3
10
4
10
5
A B
C E
D
Figure 1. Isolation and Genome Amplification of Single Human Neuronal Nuclei
(A) Schematic of the method.
(B) Fluorescence-activated cell sorting of cortical nuclei stained with NeuN shows two separable populations: NeuN+ (population I) and NeuN (population II). A
subset of population I (Ia) consisting of large neuronal nuclei was sorted and reanalyzed, confirming sort purity. Two populations of nuclei are sometimes apparent
without NeuN staining due to the increased background staining of the larger population I nuclei. Fluorescence decrease of the sorted population on re-analysis is
always observed due to photobleaching and washing of nonspecific staining in the first sort.
(C) RT-PCR confirming the neuronal and nonneuronal identities of populations Ia and II, respectively, by assaying for expression of nuclear RNA for two neuronal
(SNAP25 and SYT1), two astroglial (GFAP and AQP4), and input control (RPL37A) genes. RT-PCR and western blot experiments (Figures 1C and 1D) were
performed with NeuN/Mef2c double labeling in which all NeuN+ nuclei were Mef2c+ (data not shown).
(D) Western blot analysis of NeuN and Olig2 (an oligodendrocyte marker), confirming neuronal and nonneuronal identity, respectively, of populations Ia and II.
(E) Quantitative MDA reactions monitored in real-time confirm accurate sorting of the desired number of nuclei. The time to amplify to a threshold above
background (TimeT, analogous to qPCR CT value) is plotted on the y axis (error bars ± 1 SD; n = 7 or 8 reactions per condition). Points were fit to a semi-log line of
slope 4.3, corresponding to 1.7-fold amplification per unit time.
See also Figure S1, and see Table S3 for RT-PCR primer sequences.a systematic, regional amplification bias for all MDA samples,
compared to unamplified bulk DNA, regardless of the number
of nuclei amplified (Figure S2A). This regional bias in MDA ampli-
fication could be controlled for using any of the MDA samples as
a reference (Figure 2C), indicating that most of the regional vari-
ability in amplification is inherent to MDA rather than the number
of nuclei amplified. Bias in amplification relative to GC content
was also similar for all MDA samples types (Figure S2B).
In order to use single-neuron sequencing for somatic mutation
detection, amplified genomes must reflect the diploid genotype
(both alleles) of genomic loci. We therefore quantified the fraction
of genomic loci that failed to amplify one (allelic dropout, AD) or
both alleles (locus dropout, LD). Loss of one allele, AD, was
measured with a panel of 16 polymorphic microsatellite markers
(Identifiler fingerprinting) and by SNPmicroarray genotyping. AD
measured by Identifiler of 92 single neurons across 1,183 hetero-
zygous loci was 9.5% (Figure 2D), whereas AD measured by
SNP microarray (for >60,000 loci that are heterozygous in the
bulk DNA and called with high confidence in both the reference
and sample) was 8%–9% in three single neurons (Figure S2C
and Table S1A), consistent with previous estimates (Hou et al.,2012). Some dropout tended to recur at specific loci even in
MDA-amplified 100- and 1,000-neuron samples (Figure S2D),
probably reflecting difficulty of MDA to amplify specific loci.
Loss of both alleles, LD (locus dropout), was 2.3% in the 92
single neurons assayed by Identifiler. In addition, LD was sepa-
rately estimated by counting the percentage of low-coverage
sequencing bins with less than 1/16 the copy number relative
to an unamplified DNA reference and was 2.0% for 1-neuron
samples (Figure S2E). These low rates of AD (10%) and LD
(2%) demonstrate comprehensive and reproducible amplifica-
tion of single neuronal genomes and suggest that genome-wide
profiling of L1 insertions in single neurons could capture up to
90% of retrotransposon insertions per cell. These genotyping
controls also excluded operator contamination, as all amplified
single neuronal genomes tested were concordant with the bulk
reference (Figures 2D and 2E and Tables S1B–S1C).
Genome-wide L1Hs Profiling in Single Neurons
We performed genome-wide L1Hs insertion profiling (L1-IP) of
single neurons by adapting the method of Ewing and Kazazian
(2010) for high-throughput multiplexed sequencing. All knownCell 151, 483–496, October 26, 2012 ª2012 Elsevier Inc. 485
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Figure 2. Single-Neuron Genome-wide Coverage, Amplification Bias, and Identity Fingerprinting
(A) Schematic of the low-coverage whole-genome sequencing method.
(B) Chromosome copy numbers of single cortical neurons from normal (UMB1465, 46XY) and trisomy 18 (UMB866, 47XY, +18) individuals. Copy numbers are
normalized to the median copy number of each chromosome across the eight single neurons, with autosomes adjusted to a median copy number of 2. Orange
lines denote ± 1 copy.
(C) Higher-resolution copy number profiling in 6,000 equal-read bins of 500 kb in size shows that MDA bias can be corrected by normalization to an
MDA-amplified reference. Orange lines denote ± 1 copy, and purple points indicate off-scale bins.
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active and disease-causing L1Hs subfamilies possess two
sequences diagnostic of L1Hs (Hancks and Kazazian, 2012;
Ovchinnikov et al., 2002), and a comprehensive study of somatic
insertions in the setting of cancer found that 110/111 somatic
insertions (with evidence of a target site duplication and poly-A
tail) contained both sequences (Lee et al., 2012a). L1-IP targets
these L1Hs-specific sequences and amplifies genomic DNA
flanking L1Hs insertions containing these diagnostic sequences
(Figures 3A, 3B, and S3A).
We profiled from each of three neurologically normal individ-
uals: 50 single neurons from cerebral cortex and 50 from caudate
nucleus (i.e., 300 MDA-amplified single neurons total); unampli-
fied bulk DNA from 5–6 tissues (cortex, caudate, cerebellum,
heart, liver, and lung); MDA-amplified 50,000-cell, 10,000-cell,
1,000-cell, and 100-neuron samples; and technical replicates
to assess reproducibility (Figures S3B and S3C), for a total of
383 samples (see Table S2 for sample details). A custom data
analysis pipeline classified detected peaks as known reference
insertions present in the human genome reference (KR), known
nonreference insertions identified in previous studies (KNR), or
unknown (UNK) candidate insertions and assigned a confidence
score ranging from 0 to 1 (low-quality to high-quality peaks)
based on the number of reads and the number of unique read
start sites per peak (Figure 3A). The confidence score was
derived from a logistic regression model of germline insertions
reproducibly found in bulk DNA samples of the individual (Fig-
ure S3D and see Extended Experimental Procedures for details
of the analysis pipeline).
MDA is known to produce rare, low-level chimeric sequences
due to local, occasional mispriming of single-stranded ampli-
cons to each other during amplification (Lasken and Stockwell,
2007). These chimeras were seen in MDA-amplified samples
as an excess of background reads and peaks with low read
depth and one or few unique read start sites in the local 20 kb
flanks of some though not all L1 insertions (Figures 3B and
S4A–S4D). Because chimeras form at different sites in different
MDA reactions, they are not recurrent between samples (Fig-
ures S5A and S5B), and cloning of chimeras (representative
example in Figures S5A–S5C) confirmed their MDA-derived
mechanism of formation. Their low confidence scores (Fig-
ure S4B) allowed most MDA-chimera peaks to be filtered with
minimal reduction in sensitivity for known insertions (Figure 3C).
We first assessed the sensitivity of L1-IP to detect L1Hs inser-
tions genome-wide. In 1-neuron samples, the sensitivity of L1-IP
for KR insertions (mostly homozygous) present in bulk DNA of
the individual was 81% ± 6% (SD), with a confidence score
threshold of 0.5 (Figure S6A), and of 300 1-neuron samples in
this study, only four were low-quality outliers (Figure S6B). Sensi-
tivity increased to 87% when relaxing the confidence threshold
to 0.1, though at this lower confidence score, more candidate
insertions with weaker evidence supporting them were also de-
tected. Because somatic insertions are expected to be present(D) Identifiler fingerprinting confirms that the single neurons derive from the corre
cation (LA), allele dropout (AD), and discordant allele (DA) rates.
(E) Fraction of genotypes by SNP microarray that are concordant between three
correct individual.
See also Figure S2 and Table S1.in a single copy, sensitivity for single-copy insertions in 1-neuron
samples was assessedwith chrX KR/KNR insertions in individual
1465 (male) and was only slightly lower at 75% ± 10%, with a
confidence score threshold of 0.5 (Figure S6A). We further con-
firmed that we detect the expected absolute number of inser-
tions: the mean number of KR, KNR, and UNK insertions (with
confidence score >0.5) per bulk DNA sample was 689, 113, and
43, respectively (Figure S6C), compared to 628 KR and 152
KNR/UNK insertions found on average in a previous study (Ewing
and Kazazian, 2010). 605, 87, and 47 KR, KNR, and UNK peaks
were found on average in 1-neuron samples (Figure S6C). A
plot of L1Hs peaks found in bulk DNA, a 100-neuron sample,
and two representative single neurons is shown in Figure 4.
In order to validate L1-IP-predicted insertions, we optimized
a 30 junction PCR validation method (30PCR) (Figure S6D) and
further used it to directly measure allelic dropout (AD) and locus
dropout (LD) of L1Hs insertions in amplified single neurons. The
technical sensitivity of the 30PCR validation method (i.e., 30PCR
detection rate of true germline insertions) was important to deter-
mine first in order to estimate at what rate true insertions found
by L1-IP fail to validate by 30PCR. This was assayed by 30PCR
of 64 known germline insertions (33 KR and 31 KNR) in unampli-
fied bulk DNA and amplified unsorted 50,000-nuclei and
1-neuron samples. In 1-neuron samples, 30PCR detected 94%
of known germline insertions with the first primer attempted
(the remainder were validated successfully with redesigned
primers), and this detection rate was not significantly different
between amplified and unamplified samples (Figures 3D and
S6E). 30PCR can therefore sensitively detect L1Hs insertions in
amplified single neuronal genomes. 30PCR also successfully
validated, in both bulk and 1-neuron samples, 12 out of 12
unknown (UNK) germline candidate insertions that we tested
(Figures 3D, S6E, and Table S3), confirming that L1-IP can iden-
tify unknown germline insertions. AD of L1Hs insertions was then
estimated by 30PCR of three heterozygous insertions in a larger
number of 83 single neurons (Figures 3E, S6F, and S6G), finding
8.0% AD (20/249 alleles), consistent with previous estimates.
LD estimated by 30PCR of three homozygous insertions in the
same cells (Figures 3E and S6G) was 1.2% (3/249 alleles). We
concluded that L1-IP’s high sensitivity to detect germline inser-
tions in single neurons, our robust 30PCR validation method,
and direct confirmation of <10% L1Hs allelic dropout allow us
to confidently search for somatic L1Hs insertions genome-
wide in single neurons.
Identity Fingerprinting of Single Neurons by L1Hs Profile
L1-IP can reliably detect population-polymorphic L1Hs inser-
tions in single neurons (Figures 5A–5C), serving as a fingerprint
for each individual. All possible permutations of insertion poly-
morphisms among the three individuals were found (every
possible pair of individuals and individual specific), and as
expected, KR and KNR insertions were enriched in fixed andct individuals and measures allele preferential amplification (PA), low amplifi-
single neurons and bulk DNA confirms that the single neurons derive from the
Cell 151, 483–496, October 26, 2012 ª2012 Elsevier Inc. 487
AB
C D E
Figure 3. Genome-wide L1Hs Insertion Profiling in Single Neurons
(A) Schematic of the L1-IP method. Primers 1 and 3 (L1Hs-AC and ILMN-Adaptor1_L1Hs-G, respectively) are specific to L1Hs diagnostic nucleotides (‘‘AC’’
and ‘‘G’’). Primer 2 represents eight different 5 bp arbitrary seed primers, each containing the same barcode. Primer 4 (ILMN-SeqAdaptor2) incorporates an
Illumina adaptor. See Table S3 for primer sequences.
(B) L1-IP sequencing reads for one representative known reference insertion (L1Hs-KR-chr11_115209613). For each sample, a total read coverage track and
a raw reads track are shown. Each read coverage track is scaled to the maximum peak height of the sample (scale on the right, in reads per million mapped
reads [RPM]). In the raw reads track, up to three reads are shown for each position. The green arrow marks the L1Hs insertion. Plus and minus strand reads
are red and blue, respectively. Low-level MDA-chimera reads (yellow asterisks) are seen in the local region of the true insertion only in MDA-amplified
samples.
(C) The number of peaks found above different confidence score thresholds corresponding to known reference insertions (KR), known nonreference insertions
(KNR), and unknown peaks (UNK). Data shown are the mean for all bulk (n = 31), 100-cell (n = 15), and 1-cell (n = 303) samples from all three individuals
(includes 15, 5, and 3 technical replicates, respectively). Shading around each line shows ± SD. KR and KNR insertions used for peak annotation are in
Table S5.
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polymorphic insertions, respectively (Figure 5A). Hierarchical
clustering of all samples in the study according to L1Hs geno-
type correctly clustered all samples by individual except for three
low-quality 1-neuron samples (Figure 5A). Importantly, because
both population-polymorphic and somatic insertions belong to
the same L1Hs subfamilies and have the same L1Hs diagnostic
nucleotides (Beck et al., 2010; Lee et al., 2012a), detection of
population-polymorphic L1Hs insertions in single neuronal
genomes further illustrates that L1-IP has the potential to capture
somatic insertions.
Somatic L1Hs Insertion Rate in Cortex and Caudate
Neurons
Our single-neuron L1-IP data allowed us to quantify the number
of cortex- and caudate-specific somatic insertions in single-
neuron samples and estimate an upper bound for the number
of somatic L1Hs insertions per neuron (defined as absent
from bulk DNA samples of the individual excluding the brain
region being analyzed). Rather than using the same confidence
score threshold across all samples, we adjusted the confidence
score threshold for each single-neuron sample to maintain
a constant sensitivity for KNR germline insertions. This controls
for variability in single-neuron sample quality and allows for
more accurate correction of insertion rates for sensitivity. A
KNR reference was specifically chosen, as it would be ex-
pected to better estimate sensitivity for single-copy somatic
events than a mostly homozygous KR reference set. We
excluded insertions found within 20 kb of known (KR/KNR)
insertions, leading to a minimal reduction in sensitivity (by
excluding 1.5% of the genome, i.e., 45.5/3137 Mb) with
a substantial gain in specificity by filtering most though not all
MDA chimera peaks (Figure S4A). At a sensitivity threshold
that detects 50% of KNR insertions, we found an average of
1.1 ± 2.3 (SD) somatic insertion candidates per neuron (cor-
rected for sensitivity) (Figure 6A), and 68% of 1-neuron samples
had no detectable somatic insertions. Additionally, we counted
the number of unique somatic insertions per neuron (i.e., not
present in other single neurons sequenced from the individual)
and found 0.6 ± 1.5 (SD) candidate unique insertions per neuron
(Figure 6B); 82% of 1-neuron samples had no detectable unique
somatic insertions.
The above upper bound estimate for the somatic insertion
rate controls for sensitivity (i.e., false negative rate) but is likely
an overestimate, as it does not take into account specificity
(i.e., false positive MDA chimera and other artifactual peaks still
remaining after our sensitivity threshold and local 20 kb
filtering). We therefore screened for false positive candidates
by carrying out 30PCR validation and secondary validations of
the 16 highest-scoring candidate somatic insertions from
each tissue (96 total). Initial review of L1-IP raw data revealed
that at least half of the candidates were likely MDA-chimeras
or other recognizable technical artifacts that cannot be system-(D) Representative gel images of 30 junction PCR (30PCR) of 20 different germline
(E) 30PCR quantification of AD and LD in 1-neuron samples (n = 83) of three heter
heterozygous and homozygous insertions, respectively. NL, normal amplification
See also Figures S3, S4, S5, and S6, and Tables S2, S3, and S5.atically filtered. These include peaks caused by read alignment
errors, chimeras of older L1Pa insertions, and loci with system-
atic low-level reads present at subthreshold levels in many
unamplified bulk and MDA-amplified samples of unrelated indi-
viduals but stochastically passing threshold as somatic candi-
dates in one or a few single-neuron samples (see Table S3
for annotation of the 96 candidates). Indeed, only 17 of the
81 candidates (21%) for which we could design primers passed
30PCR validation (Figure S7A), significantly less than the 94%
validation rate for known insertions (Figure S6E). Secondary
validation sequencing of 30PCR products and review of L1-IP
raw data revealed that 12 of the remaining 17 candidates
were chimeras or nonspecific PCR products. Therefore, most
of the somatic candidates are likely false positives, and the
true somatic L1Hs insertion rate may be significantly lower
than our upper bound estimate prior to validation. The postva-
lidation somatic and unique somatic insertion rate estimates
are 0.07 ± 0.15 (SD) and 0.04 ± 0.10 (SD) insertions per neuron,
respectively (Figures 6A and 6B).
The remaining five somatic candidates were studied further
by attempting to clone their full lengths and screening for their
presence by 30PCR across all single neurons sorted from the
individual in which they were found. We successfully cloned
the full length of one of the five somatic insertion candidates
(Figure S7B). This insertion was detected in our L1-IP data in
intron 4 of the gene IQCH (IQ motif containing H, chromo-
some 15), in neuron #2 from the cortex of individual 1465,
and is a full-length, intact 6.1 kb L1Hs with all of the hallmarks
of a bona fide L1Hs insertion: a target site duplication (TSD)
(13 bp), a poly-A tail (71 bp), and a 50 transduction
(101 bp), allowing us to trace its source to a full-length, pop-
ulation-polymorphic KR L1Hs on chromosome 8 (Figures 6D,
S7C and S7D). The full-length sequence of the somatic inser-
tion (Table S3) precisely matched the sequence of the source
L1Hs. The insertion was not detected by standard 30PCR in
brain and nonbrain bulk tissues from the individual (Figure 6C)
and was found in 2/83 (2.4%) cortical and 0/59 caudate single
neurons tested (Figure 6E). The insertion was detected at low
levels in L1-IP data of some unsorted 50,000-nuclei samples
(Figure S7E), as expected for a low-level mosaic insertion,
and with further optimization of our 30PCR protocol (increased
DNA input and higher-cycle PCR), we were able to amplify the
insertion from these bulk samples as well (Figure S7F). The re-
maining four candidates were each found by 30PCR only in
the single neuron in which they were identified by L1-IP. Three
of the four had poly-A tails by 30PCR product sequencing (the
fourth had an indeterminate poly-A tail because the break-
point was within a genomic poly-A) (Table S3). Our results
illustrate the ability of single-cell sequencing to identify
somatic L1Hs insertions and highlight the potential of single-
cell sequencing to identify very low-level mosaic mutations
in human tissue.insertions (8 KR, 8 KNR, and 4 UNK).
ozygous and three homozygous L1Hs insertions. AD and LD are quantified for
; LA, low amplification; AD, allelic dropout; LD, locus dropout.
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Figure 4. Chromosome L1-IP Profile of Single Neurons
(A–D) Circos plot (Krzywinski et al., 2009) of chromosomes 1 and 2 from representative L1-IP samples from individual 1465: (A) bulk DNA, (B) cortex
100-neurons #1, (C) cortex 1-neuron #2, and (D) caudate 1-neuron #1. Peaks are shown for loci in which at least one of the samples has a peak confidence
score > 0.5. Bulk DNA track shows themean confidence score across all bulk DNA samples of individual 1465. KR, KNR, and UNK peaks are colored as indicated
in the key. Below 100-neuron and 1-neuron sample tracks are annotations for peaks present with a score >0.5 in bulk DNA but absent in the sample (‘‘Dropout’’)
and peaks absent from bulk DNA but present in the sample with a score >0.5 and at least 20 kb away from the nearest KR/KNR insertion in the individual to
exclude MDA-chimera peaks (‘‘Somatic peak’’). Figures for all chromosomes can be found in Data S1.Single-Cell Sequencing Quantifies Mosaicism of
a Somatic BrainMutationCausingHemimegalencephaly
Given the low rate of L1 retrotransposition in neocortical progen-
itors of normal brains, we next studied the ability of single-neuron
sequencing to characterize a pathogenic somatic point mutation490 Cell 151, 483–496, October 26, 2012 ª2012 Elsevier Inc.in the brain. An open question regarding the pathophysiology of
hemimegalencephaly is the lineage (developmental origin) of the
pathologic cells (Flores-Sarnat et al., 2003). We recently identi-
fied a child with isolated hemimegalencephaly (HMG) caused
by a somatic missense (p.E17K) point mutation in AKT3 present
AB C
Figure 5. Single-Neuron Fingerprinting with L1-IP
(A) Unbiased hierarchical clustering of all samples sequenced in this study (excluding technical replicates) by transposon profile. Each row represents a sample,
and each column represents a specific L1Hs insertion. Data are shown for all KR and KNR insertions with an average score of at least 0.5 in at least one indi-
vidual’s samples. Black and white squares indicate presence or absence, respectively, of the insertion using a confidence score threshold of 0.5. All samples
cluster correctly by individual except for three low-quality 1-neuron samples that cluster in a separate branch (bottom branch). Additional row annotations are
colored for individual (I), sample type (S), and tissue (T), illustrating correct clustering by individual. Column annotations show annotation for KR (black) and KNR
(white) insertions and mean confidence scores across all samples of each individual. Samples also cluster by individual when including all insertions including
unknown peaks (data not shown).
(B) L1-IP read coverage for a representative polymorphic known nonreference insertion (L1Hs-KNR-1158).
(C) Representative gel images of 30PCR of 11 polymorphic germline insertions with 1-neuron DNA. 30PCR products are only detected in individuals predicted by
L1-IP to have the insertion. All polymorphic insertions tested are listed in Table S3.
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Figure 6. Quantification of Somatic L1Hs Insertions and Validation of a Somatic Insertion in Single Neurons
(A) Mean number (±SD) of somatic insertion candidates per single neuron in each tissue in the study, corrected for sensitivity. The estimated insertion rates per
neuron are shown before and after 30PCR and secondary validation. Horizontal dashed lines and adjacent numbers indicate the mean number of insertion
candidates across all single neurons from all tissues. Low-quality samples that did not achieve the necessary KNR detection rate with a confidence score >0.5
were excluded from the analysis in a quality control check (‘‘QC-fail’’ in Table S2). The number of cells included in each analysis were n = 50, 45, 45, 50, 50, and 44
for 1465 cortex, 1465 caudate, 4638 cortex, 4638 caudate, 4643 cortex, and 4643 caudate, respectively, after removing low-quality samples failing quality
control.
(B) Mean number (±SD) of unique somatic insertion candidates (i.e., present in only one single-neuron sample of the individual) per single neuron in each tissue,
corrected for sensitivity.
(C) Gel images of 30PCR validation of a somatic L1Hs insertion found by L1-IP in individual 1465 cortex 1-neuron #2 (L1-IP peak ID chr15_67625710_plus_0_0).
(D) Location of the somatic L1Hs insertion (L1-IP peak ID chr15_67625710_plus_0_0) in antisense orientation in intron 4 of the gene IQCH and the corresponding
L1-IP peak in 1465 cortex 1-neuron #2. The insertion’s target site duplication coordinates are chr15: 67,625,702–67,625,714 (hg19). A 50 transduction (orange)
identified the source L1Hs on chr8: 73,787,792–73,793,823.
(E) Representative gel images from a 30PCR screen of 83 1-neuron samples from individual 1465 cortex (24 1-neuron samples shown) for the somatic insertion in
Figures 6C and 6D. The two cortical 1-neuron samples (#2 and #77) found to have the insertion are shown. 1-neuron #77was found to have the insertion only in the
30PCR screen because it was not profiled by L1-IP. 30PCR product sequencing and full-length cloning confirmed that the insertion had identical 50 and 30
breakpoints and TSD in both neurons (#2 and #77).
See also Figure S7 and Table S3.in the brain, but not in the blood (case HMG-3, Poduri et al., 2012)
(Figure 7A). Due to intractable epilepsy, the malformed hemi-
sphere was surgically removed, allowing application of our
single-cell method to genotype single sorted cells from this
surgical sample and to study the origin of the pathologic cells.
Previous analysis of resected bulk tissue indicated that the
mutation was present at 35% mosaicism based on cloning of
PCR products (Poduri et al., 2012). Interestingly, 39% ± 7%492 Cell 151, 483–496, October 26, 2012 ª2012 Elsevier Inc.(SE; corrected for AD) of single sorted neuronal (NeuN+) nuclei
contained themutation (Figures 7B and 7C and Table S4), similar
to the mosaicism in unsorted bulk tissue containing both
neuronal and nonneuronal cells. This suggested that the muta-
tion was also present in nonneuronal cells, consistent with the
abnormality of both gray matter and white matter in this patient
by MRI (Poduri et al., 2012; Figure 7A). Indeed, we confirmed
the presence of the mutation in single nonneuronal (NeuN)
AC
B
Figure 7. Single-Cell Analysis of a Somatic Brain AKT3 Mutation Causing Hemimegalencephaly
(A) An axial T2-weighted image from the MRI of the hemimegalencephaly patient, HMG-3, with a somatic AKT3 E17K mutation shows the enlarged right
hemisphere with abnormally thick andmalformed cerebral graymatter and abnormal signal of the white matter (white dashed line). On the right is anMRI image of
a normal brain.
(B) Single-cell FACS sorting of HMG-3 resected cortex.
(C) Representative Sanger sequencing traces of a bulk unsorted nuclei sample and single-cell samples from NeuN+ and NeuN populations. The calculated
percent mosaicism for single-cell samples (corrected for allelic dropout) is shown. Arrow and asterisks mark the site of the AKT3 c.49G/A (p. E17K) mutation.
See Table S3 for primer sequences, and see Table S4 for percent mosaicism of all samples from HMG-3.nuclei, at an average percent mosaicism (corrected for AD) of
27% ± 8% (Figure 7C and Table S4). These data indicate that
the mutation was present in an early neocortical progenitor
capable of giving rise to both neuronal and nonneuronal cells
throughout the majority of the hemisphere. The low mosaicism
in neurons also indicates that mutant and nonmutant neurons
are extensively intermingled in the abnormal hemisphere,
presumably reflecting diverse clonal origins of cortical neurons
in this pathological condition.
DISCUSSION
Here, we present a single-cell sequencing study of the central
nervous system and perform genome-wide analysis to trace
patterns of somatic mutation in human brain. We confirmed
that somatic retrotransposon insertions can be detected in
normal human brain. However, our analysis of L1 insertions
found that somatic insertions are rare in normal human cortical
and caudate neurons, suggesting that L1 retrotransposition is
not a major source of neuronal diversity in cerebral cortex andcaudate nucleus. Finally, we used single-cell analysis to study
the mosaicism of a somatic AKT3 mutation, highlighting the
potential of single-cell sequencing for cell lineage analysis in
human brain.
L1Hs Retrotransposition in Human Cerebral Cortex
and Caudate Nucleus
Our validation of a somatic L1Hs insertion with all of the hall-
marks of a bona fide retrotransposition event, including a 50
transduction identifying its source, confirms that somatic L1Hs
insertions are present in the normal human brain. The very
low-level mosaicism of this insertion and its detection only in
cortical neurons further suggest that it may have occurred during
cortical development. The source L1Hs on chromosome 8 from
which the somatic insertion originated lies in antisense orienta-
tion within an intron of the gene KCNB2 and is a full-length inser-
tion with both open reading frames intact. Although it is present
in the human genome reference, it is polymorphic in the popula-
tion and was present only in individual 1465, but not in the other
individuals in this study (data not shown). In addition to thisCell 151, 483–496, October 26, 2012 ª2012 Elsevier Inc. 493
source L1Hs, only one other L1Hs element has been previously
confirmed to be active somatically in humans (Van den Hurk
et al., 2007). Further single-cell studies will help to delineate
the spectrum of somatic activity of L1Hs elements in different
tissues and developmental stages.
Our quantitative analysis of retrotransposition indicates that
somatic L1Hs events are rare in adult human cortical pyramidal
neurons and caudate neurons. We find that, although we
can detect hundreds of known germline insertions in single
neurons, >80% of neurons show no unique somatic insertions
(i.e., present in one neuron, but not multiple neurons). Somatic
L1Hs insertions present in multiple neurons, but not all neurons,
as seen for the full-length somatic insertion that we identified, are
also rare. On the other hand, we cannot exclude greater rates of
L1Hs activity in other cell types or regions of the human brain,
or activity of Alu and SVA retrotransposons in the cortex and
caudate. Variability in the number of highly active ‘‘hot’’ L1s
per individual (Beck et al., 2010) may also lead to variability in
somatic retrotransposition rates among individuals; however,
the low number of somatic insertions in 300 neurons from three
individuals precludes it from being an essential source of
neuronal diversity in cortex and caudate that is common in
humans.
Our results are generally consistent with the rates of
1/10,000 to1/100 insertion events per human neural progen-
itor measured in an in vitro L1RP reporter assay (Coufal et al.,
2009). This rate is far lower than the rate measured by quanti-
tative PCR (Coufal et al., 2009; Muotri et al., 2010), which esti-
mated a relative copy number increase of L1 of 5%–10%
and an absolute estimate of 80 somatic L1 insertions per cell
in human brain. Studies employing targeted capture of L1
sequences from human brain (Baillie et al., 2011) also reported
widespread L1 retrotransposition. Thesemethods are less direct
and do not analyze individual neurons but instead analyze
pooled DNA from bulk tissue. Compared to sequencing of bulk
tissue (Baillie et al., 2011), our approach of single-cell
sequencing has the additional advantage that potential artifacts,
such as chimeric reads, are easier to recognize because they are
present at lower read depth relative to true insertions. The iden-
tification of mammalian species that appear to have lost all L1
activity (Cantrell et al., 2008) further suggests that L1 retrotrans-
position is not a universal requirement for mammalian neurogen-
esis. Recent L1 profiling of 26 glial brain tumors did not reveal
any somatic insertions (Iskow et al., 2010; Lee et al., 2012a), indi-
cating that somatic L1 insertions may be uncommon in glial
progenitors as well. Though our study suggests that somatic
L1 retrotransposition in the human cortex and caudate is rare,
it remains possible that neuronal L1 retrotransposition may
occur at higher rates in other brain regions, such as the hippo-
campus, and/or may play a role as a mutagen in the human brain
in neurological disease.
Somatic Mutations Causing Cortical Malformations Can
Occur in Neuroglial Progenitors
Our analysis of a somatic retrotransposon insertion and
a somatic AKT3 mutation, each found in more than one cortical
neuron as well as at low levels in bulk DNA, suggests that both
occurred in progenitor cells of the brain and that other focal brain494 Cell 151, 483–496, October 26, 2012 ª2012 Elsevier Inc.malformations of unknown etiology may be similarly caused by
progenitor mutations during development. The somatic AKT3
mutation in hemimegalencephalic brain was found in both
neuronal and nonneuronal cells, further indicating that the muta-
tion occurred in a neuroglial progenitor. Moreover, the normal-
appearing basal ganglia of this patient by MRI (data not shown)
would be consistent with a mutation occurring in a neuroglial
progenitor in the developing neocortex, but not involving the
ventral telencephalon, though caudate tissue was not available
for testing.
Our study suggests potential future applications of somatic
mutations as cell lineage markers in postmortem human brain.
Although retrotransposon insertions appear too rare for system-
atic study of cell lineages and the specific AKT3 mutation
assayed here clearly changes the behavior of cells carrying the
mutation (Poduri et al., 2012), deeper sequencing of single cells
might eventually identify diverse, nonfunctional mutations,
including mutations at highly mutable sites like microsatellite
repeats (Frumkin et al., 2005; Salipante et al., 2008), which
may allow more systematic interrogation of lineage relationships
even in human postmortem brain.EXPERIMENTAL PROCEDURES
Full protocols can be found in the Extended Experimental Procedures.Tissue Sources
Fresh-frozen postmortem tissues of three normal individuals and a trisomy 18
fetus (UMB1465, UMB4638, UMB4643, and UMB866) were obtained from the
NICHD Brain and Tissue Bank at the University of Maryland. Hemimegalence-
phalic brain tissue from case HMG-3 (Poduri et al., 2012) was obtained
following neurosurgical resection of the affected right hemisphere.Single Neuronal Nuclei Isolation and Genome Amplification
Nuclei were purified by sucrose cushion ultracentrifugation and labeled with
NeuN antibody (Millipore, MAB377) for flow cytometry as previously described
(Matevossian and Akbarian, 2008; Spalding et al., 2005). Single nuclei were
sorted with a FACSAria II cell sorter into 96- or 384-well plates and amplified
by MDA (Dean et al., 2002). Low-coverage sequencing libraries were made
with the NEXTflex DNA-seq kit (Bioo Scientific).Genome-wide L1Hs Insertion Profiling
L1Hs insertion profiling (L1-IP) libraries were made by modification of the
method of Ewing and Kazazian (2010) for a high-throughput workflow and
high-level (up to 32-plex) multiplexing. Libraries were sequenced on HiSeq
2000 sequencers (Illumina). A custom data analysis pipeline was created to
call and classify L1-IP peaks.L1Hs Insertion Validation
30 junction PCR (30PCR) was performed with one primer specific to L1Hs
(L1Hs-AC-22) and a 50 peak flank primer (upstream to the L1-IP peak) to verify
the presence of the predicted insertion. Full-length (long-range) PCR with 50
and 30 peak flank primers was performed to clone the entire length of candi-
date insertions.ACCESSION NUMBERS
Sequencing data from this study are deposited in the NCBI Sequence Read
Archive (http://www.ncbi.nlm.nih.gov/sra) under the accession number
SRA056303.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, six tables, and one data file and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2012.09.035.
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